Barinthus Biotherapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development of antigen-specific immunotherapeutics that induce T cells to treat chronic viral infections, autoimmune diseases, and cancer. It also focuses on the pipeline of both clinical and preclinical stage therapeutic, and prophylactic programs. The company was founded by Adrian Hill and Dame Sarah Gilbert in March 2021 and is headquartered in Didcot, the United Kingdom.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
105
Frequently Asked Questions
What is Market Cap of Barinthus Biotherapeutics Plc. - ADR?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Barinthus Biotherapeutics Plc. - ADR market cap is $53.66M.
What is the 52-week high for Barinthus Biotherapeutics Plc. - ADR?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Barinthus Biotherapeutics Plc. - ADR 52 week high is $2.92 as of September 06, 2025.
What is the 52-week low for Barinthus Biotherapeutics Plc. - ADR?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Barinthus Biotherapeutics Plc. - ADR 52 week low is $0.64 as of September 06, 2025.
What is Barinthus Biotherapeutics Plc. - ADR stock price today?
Barinthus Biotherapeutics Plc. - ADR stock price today is $1.24.
What was Barinthus Biotherapeutics Plc. - ADR stock price yesterday?
Barinthus Biotherapeutics Plc. - ADR stock price yesterday was $1.33.
What is the PE ratio of Barinthus Biotherapeutics Plc. - ADR?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Barinthus Biotherapeutics Plc. - ADR’s P/E ratio is -0.77.
What is the Price-to-Book ratio of Barinthus Biotherapeutics Plc. - ADR?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Barinthus Biotherapeutics Plc. - ADR P/B ratio is 0.5250.
What is the 50-day moving average of Barinthus Biotherapeutics Plc. - ADR?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Barinthus Biotherapeutics Plc. - ADR 50-day moving average is $1.26.
How many employess does Barinthus Biotherapeutics Plc. - ADR has?
Barinthus Biotherapeutics Plc. - ADR has 105 employees.
